54350-48-0: Acitretin EP Impurity B
Acitretin EP Impurity B (CAS No: 54350-48-0) or Acitretin Related Compound B / Etretinate is a novel aromatic retinoic acid derivative used for the treatment of severe psoriasis and dyskeratoses. It acts by normalizing pathological variations in epidermal and dermal skin, especially by inhibiting hyperkeratinisation and cell differentiation.
Ethyl (2E, 4E, 6E, 8E)-9-(4-methoxy-2, 3, 6-trimethylphenyl)-3, 7-dimethylnona-2, 4, 6, 8-tetraenoate
Acitretin Related Compound B/ Etretinate
?Ward, A., et al. “Etretinate a Review of Its Pharmacological Properties and Therapeutic Efficacy in Psoriasis and Other Skin Disorders.” Drugs, vol. 26, no. 1, July 1983, pp. 9–43, https://doi.org/10.2165/00003495-198326010-00002.